Related Experiment Videos
[Neutrophil granulocyte function in patients with malignant neoplasms]
Voprosy Onkologii
|January 1, 1989
Summary
Polymorphonuclear neutrophils (PMN) show altered function in advanced lung and stomach cancer patients. Their cytotoxic activity is heightened but unresponsive to stimuli, indicating potential immune dysregulation in cancer.
Area of Science:
- Oncology
- Immunology
- Hematology
Background:
- Advanced lung and stomach cancers (Stage III-IV) are associated with significant systemic changes.
- Immune cell function, particularly neutrophils, can be profoundly affected by malignancy.
Purpose of the Study:
- To investigate the functional status of polymorphonuclear neutrophils (PMN) in untreated patients with Stage III-IV lung and stomach cancer.
- To compare PMN activity and characteristics between cancer patients and healthy individuals.
Main Methods:
- Analysis of peripheral blood neutrophil counts and leukocyte cationic protein levels.
- In vitro assessment of PMN cytotoxic activity against K-562 cells.
- Evaluation of neutrophil responsiveness to stimuli and NBT-test values.
Main Results:
- Untreated cancer patients exhibited a marked increase in peripheral blood neutrophil counts.
- A decrease in leukocyte cationic protein levels was observed in cancer patients.
- PMN from cancer patients displayed significantly higher in vitro cytotoxic activity against K-562 cells compared to controls.
- This heightened activity was not accompanied by a typical reactive response to stimuli.
- The NBT-test value variation range was wider in cancer patients.
Conclusions:
- Polymorphonuclear neutrophils in advanced lung and stomach cancer patients show distinct functional alterations.
- Elevated cytotoxic activity of PMN in cancer, independent of stimuli response, suggests a dysregulated immune state.
- These findings highlight potential roles for PMN in cancer progression and immune evasion.